Cytokine profile in Montenegro skin test of patients with localized cutaneous and mucocutaneous leishmaniasis

Revista do Instituto de Medicina Tropical de Sao Paulo

Volumn 50, Issue 6, 2008, Pages 333-337

  Nogueira, Marcia Ferraz ^a,c   Goto, Hiro ^b   Sotto, Mírian Nacagami ^b   Cucé, Luiz Carlos ^b  

^a UNIVERSITY OF SANTO AMARO   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c NONE   (Brazil)

Author keywords

Cytokines; Delayed type hypersensitivity; Human cutaneous leishmaniasis; Immunopathology; Skin

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5;

ADULT; AGED; ARTICLE; BIOPSY; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; HUMAN; LEISHMANIN SKIN TEST; LOCALIZED CUTANEOUS LEISHMANIASIS; MALE; OUTCOME ASSESSMENT; PARASITIC SKIN DISEASE; PROTEIN EXPRESSION; SKIN LEISHMANIASIS;

EID: 58049195472     PISSN: 00364665     EISSN: 16789946     Source Type: Journal    
DOI: 10.1590/S0036-46652008000600004     Document Type: Article

References (33)

1. BOSQUE, F.; SARAVIA, N.G.; VALDERRAMA, L. & MILON, G. - Distinct innate and acquired immune responses to Leishmania in putative susceptible and resistant human populations endemically exposed to L. (Viannia) panamensis infection. Scand. J. Immunol., 51: 533-541, 2000.
2. BOTTREL, R.L.; DUTRA, W.O.; MARTINS, F.A. et al. - Flow cytometric determination of cellular sources and frequencies of key cytokine-producing lymphocytes directed against recombinant LACK and soluble Leishmania antigen in human cutaneous leishmaniasis. Infect. Immun., 69: 3232-3239, 2001.
3. BRASIL. Ministério da Saúde - Manual de vigilância da Leishmaniose tegumentar americana. 2. ed. Brasília, Editora do Ministério da Saúde, 2007.
4. CARVALHO, E.M.; BARRAL, A.; COSTA, J.M.; BITTENCOURT, A. & MARSDEN, P. - Clinical and immunopathological aspects of disseminated cutaneous leishmaniasis. Acta trop. (Basel), 56: 315-325, 1994.
5. CARVALHO, E.M.; CORREIA FILHO, D.; BACELLAR, O. et al. - Characterization of the immune response in subjects with self-healing cutaneous leishmaniasis. Amer. J. trop. Med. Hyg., 53: 273-277, 1995.
6. CARVALHO, E.M.; JOHNSON, W.D.; BARRETO, E. et al. - Cell mediated immunity in American cutaneous and mucosal leishmaniasis. J. Immunol., 135: 4144-4148, 1985.
7. CARVALHO, L.P.; PASSOS, S.; BACELLAR, O. et al. - Differential immune regulation of activated T cells between cutaneous and mucosal leishmaniasis as a model for pathogenesis. Paras. Immunol., 29: 251-258, 2007.
8. CASTRO, R.M.; NANNI, M.E.E.; ERMETICCE, L.E. & TOYODA K. - The positivation of Montenegro test during the treatment of mucocutaneous Leishmaniasis. A case report. Rev. Inst. Med. trop. S. Paulo, 14: 338-339, 1972.
9. CONCEIÇÃO-SILVA, F.; DÓREA, R.C.C.; PIRMEZ, C.; SCHUBACH, A. & COUTINHO, S.G. - Quantitative studies of Leishmania braziliensis reactive T cells in peripheral blood and in the lesions of patients with American mucocutaneous Leishmaniasis. Clin. exp. Immunol., 79: 221-226, 1990.
10. CONVIT, J.; PINARDI, M.E. & RONDON, A.J. - Diffuse cutaneous leishmaniasis; a disease due to an immunological defect of the host. Trans. roy. Soc. trop. Med. Hyg., 66: 603-610, 1972.
11. COUTINHO, S.G.; OLIVEIRA, M.P.; DA-CRUZ, A.M. et al. - T-cell responsiveness of American cutaneous leishmaniasis patients to purified Leishmania pifanoi amastigote antigens and Leishmania braziliensis promastigote antigens: immunologic patterns associated with cure. Exp. Parasit., 84: 144-155, 1996.
12. D'OLIVEIRA Jr., R.A.; MACHADO, P.; BACELLAR, O. et al. - Evaluation of IFN-gamma and TNF-alpha as immunological markers of clinical outcome in cutaneous leishmaniasis. Rev. Soc. bras. Med. trop., 35: 7-10, 2002.
13. DA-CRUZ, A.M.; BITTAR, R.; MATTOS, M. et al. - T-cell-mediated immune responses in patients with cutaneous or mucosal leishmaniasis: long-term evaluation after therapy. Clin. Diagn. Lab. Immunol., 9: 251-256, 2002.
14. DIAZ, N.L.; ZERPA, O.; PONCE, L.V. et al. - Intermediate or chronic cutaneous leishmaniasis: leukocyte immunophenotypes and cytokine characterization of the lesion. Exp. Derm., 11: 34-41, 2002.
15. FOLLADOR, I.; ARAUJO, C.; BACELLAR, O. et al. - Epidemiologic and immunologic findings for the subclinical form of Leishmania braziliensis infection. Clin. infect. Dis., 34: E54-58, 2002.
16. GUARIN, N.; PALMA, G.I.; PIRMEZ, C. et al. - Comparative immunohistological analysis of the Montenegro skin test reaction in asymptomatic infection and in acute and chronic cutaneous leishmaniasis. Biomedica, 26 (suppl. 1): 38-48, 2006.
17. LAINSON, R. - Leishmania e leishmaniose com particular referência à Região Amazônica. Rev. Paraen. Med., 11(1): 29-40, 1997.
18. LAUNOIS, P.; LOUIS, J.A; & MILON, G. - The fate and persistence of Leishmania major in mice of different genetic backgrounds: an example of exploitation of the immune system by intracellular parasites. Parasitology, 115 (suppl.): S25-32, 1997.
19. LOUZIR, H.; MELBY, P.C.; BEN SALAH, A. et al. - Immunologic determinants of disease evolution in localized cutaneous leishmaniasis due to Leishmania major. J. infect. Dis., 177: 1687-1695, 1998.
20. MARTÍNEZ-ARENDS, A.; TAPIA, F.J.; CÁCERES-DITTMAR, G. et al. - Immunocytochemical characterization of immune cells in lesions of American cutaneous leishmaniasis using novel T cell markers. Acta trop. (Basel), 49: 271-280, 1991.
21. MELO, M.N.; MAYRINK, W.; COSTA, C.A. et al. - Padronizaç ão do antígeno de Montenegro. Rev. Inst. Med. trop. S. Paulo, 19: 161-164, 1977.
22. MODLIN, R.L.; TAPIA, F.J.; BLOOM, B.R. et al. - In situ characterization of the cellular immune response in American cutaneous leishmaniasis. Clin. exp. Immunol., 60: 241-248, 1985.
23. MONTENEGRO, J. - A cutis-reação na leishmaniose. An. Fac. Med. S. Paulo, 1: 323-330, 1926.
24. NASCIMENTO, M.D.S.B.; ALCÂNTARA-NEVES, N.M.; MUNIZ, M.E.B. et al. - Induction and modulation of the immune response to Leishmania by Montenegro's skin test. Trans. roy. Soc. trop. Med. Hyg., 87: 91-93, 1993.
25. PIRMEZ, C.; COOPER, C.; PAES-OLIVEIRA, M. et al. - Immunologic responsiveness in American cutaneous leishmaniasis lesions. J. Immunol., 145: 3100-3104, 1990.
26. PIRMEZ, C.; YAMAMURA, M.; UYEMURA, K. et al. - Cytokine patterns in the pathogenesis of human leishmaniasis. J. clin. Invest., 91: 1390-1395, 1993.
27. SACKS, D. & NOBEN-TRAUTH, N. - The immunology of susceptibility and resistance to Leishmania major in mice. Nature Rev. Immunol., 2: 845-858, 2002.
28. SALLES GOMES, L. - A intradermo-reação de Montenegro na leishmaniose e outras pesquisas afins. Brasil-méd., 53:1079-1087, 1939.
29. SASSI, A.; LOUZIR, H.; BEN SALAH, A. et al. - Leishmanin skin test lymphoproliferative responses and cytokine production after symptomatic or asymptomatic Leishmania major infection in Tunisia. Clin. exp. Immunol., 116: 127-132, 1999.
30. SCHUBACH, A.; CUZZI-MAYA, T.; OLIVEIRA, A.V. et al. - Leishmanial antigens in the diagnosis of active lesions and ancient scars of American tegumentary leishmaniasis patients. Mem. Inst. Oswaldo Cruz, 96: 987-996, 2001.
31. SILVEIRA, F.T.; BLACKWELL, J.M.; ISHIKAWA, E.A. et al. - T cell responses to crude and defined leishmanial antigens in patients from the lower Amazon region of Brazil infected with different species of Leishmania of the subgenera Leishmania and Viannia. Paras. Immunol., 20: 19-26, 1998.
32. SOTTO, M.N.; YAMASHIRO-KANASHIRO, E.H.; MATTA, V.L.R. & BRITO, T. - Cutaneous leishmaniasis of the New World: diagnostic immunopathology and antigen pathways in skin and mucosa. Acta trop. (Basel), 46: 121-130, 1989.
33. World Health Organization - The leishmaniases and leishmania/HIV co-infections. Fact Sheet No. 116, revised May 2000. http://www.who.int/ mediacentre/factsheets/fs116/en/print.html